Adaptive Biotechnologies Corporation (ADPT) NASDAQ

12.56

+0.15(+1.21%)

Updated at August 19 04:00PM

Currency In USD

Valuation

Market Cap882.61M
Enterprise Value924.08M
P/E Ratio-15.76
PEG Ratio-1.08
Price/Sales Ratio9.32
Price/Book Ratio10.63
Enterprise/Revenue9.52
Enterprise/EBITDA-19.81

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.59
Operating Margin-0.59

Management Effectiveness

Return On Assets-0.24
Return On Equity-0.61

Income Statement

Revenue178.96M
Revenue/Share1.35
Gross Profit106.88M
EBITDA-128.76M
Net Income-159.49M
Diluted EPS-1.08

Balance Sheet

Total Cash197.87M
Total Cash/Share1.3
Total Debt84.37M
Total Debt/Equity0.47
Current Ratio2.84
Book Value Per Share1.18

Price History

52-Week Change161.12
52-Week High13.37
52-Week Low3.98
Moving Average 50 Days11.25
Moving Average 200 Days8.37

Statistics

Average Volume1.99M
Shares Outstanding152.27M
% Held by Institutions101.07

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A